Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Effects of Colipral® (E.Coli 5C LMG S-33222) on Microbiota Gut Composition in Patients Presenting With Ulcerative Colitis During Remission Phase and Functional Disorders

NCT07751081 is registered in ClinicalTrials.gov with University of Padova as lead sponsor.

NCT NCT07751081
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07751081 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Effects of Colipral® (E.Coli 5C LMG S-33222) on Microbiota Gut Composition in Patients Presenting With Ulcerative Colitis During Remission Phase and Functional Disorders
Lead sponsor
University of Padova
Phase
Not applicable
Overall status
Not yet recruiting
Start date
September 1, 2026
Completion date
March 31, 2028
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

functional disorder of gastrointestinal tract, inflammatory bowel disease, ulcerative colitis type